H&R GmbH & Co. KGaA Unveils Exciting H1 2024 Interim Report

• H&R GmbH & Co. KGaA achieved consolidated operating earnings (EBITDA) of EUR 41.1 million in the first half of 2024, slightly higher than EUR 39.4 million in H1 2023.
• Sales revenues for the first half of 2024 were EUR 675.6 million, a decrease from EUR 699.6 million in H1 2023.
• The company's EBIT for H1 2024 was EUR 11.7 million, compared to EUR 11.1 million in H1 2023.
• Net income attributable to shareholders was EUR 2.8 million in H1 2024, down from EUR 3.7 million in H1 2023, resulting in earnings per share of EUR 0.07.
• The full-year EBITDA forecast remains unchanged, expected to be between EUR 90.0 million and EUR 110.0 million.
• H&R KGaA is a specialty-chemicals company listed on the Frankfurt Stock Exchange's Prime Standard segment, developing and manufacturing chemical and pharmaceutical specialty products and high-precision plastic parts.

The next important date, Publication of the semi-annual financial report, at H&R is on 14.08.2024.

The price of H&R at the time of the news was 3,6950EUR and was down -3,27 % compared with the previous day.
8 minutes after the article was published, the price was 3,7400EUR this corresponds to a plus of +1,22 % since publication.

H&R

+0,53 %

-2,30 %

-3,29 %

-21,40 %

-20,75 %

-61,72 %

-40,03 %

-43,67 %

-34,36 %

ISIN:DE000A2E4T77WKN:A2E4T7

• Intraday
• 5 Tage
• 1 Monat
• 3M
• 1 Jahr
• 3J
• 5J
• 10J
• Max